Singapore - englanti - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - ibrutinib - tablet, film coated - ibrutinib 280mg

Singapore - englanti - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - ibrutinib - tablet, film coated - ibrutinib 420mg

Singapore - englanti - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - ibrutinib - tablet, film coated - ibrutinib 560mg

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - ibrutinib 140mg;  ;   - capsule - 140 mg - active: ibrutinib 140mg     excipient: croscarmellose sodium gelatin magnesium stearate microcrystalline cellulose opacode black s-1-17822 opacode black s-1-17823 sodium laurilsulfate titanium dioxide - imbruvica is indicated for the treatment of · patients with mcl who have received at least one prior therapy

Armenia - englanti - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

mucos emulsions gmbh - bromelain, trypsin, rutin - tablets gastro-resistant - 450fip-u+ 1440fip-u(24mckat)+ 100mg

Armenia - englanti - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

apotex inc. - sucralfate - tablets - 1000mg

Israel - englanti - Ministry of Health

teva israel ltd - caffeine anhydrous; chlorpheniramine maleate; paracetamol; phenylephrine hydrochloride - tablets - paracetamol 300 mg; chlorpheniramine maleate 2.0 mg; phenylephrine hydrochloride 10 mg; caffeine anhydrous 30 mg - phenylephrine, combinations - symptomatic relief of common cold, congestion associated with sinusitis, allergic rhinitis accompanied by fever and pain.

Israel - englanti - Ministry of Health

teva israel ltd - furosemide - tablets - furosemide 40 mg - furosemide - edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. adjunctive therapy in acute pulmonary edema. treatment of hypertension.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - ibrutinib 140mg;  ;   - film coated tablet - 140 mg - active: ibrutinib 140mg     excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry green 85f210036 povidone sodium laurilsulfate - imbruvica is indicated for the treatment of · patients with mcl who have received at least one prior therapy

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - ibrutinib 280mg;  ;   - film coated tablet - 280 mg - active: ibrutinib 280mg     excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry purple 85f200011 povidone sodium laurilsulfate - imbruvica is indicated for the treatment of · patients with mcl who have received at least one prior therapy